Abstract
A new no-touch aqueous spray has been developed for the topical treatment of pruritus ani. It contains 0.2% hydrocortisone and 1.0% lignocaine hydrochloride, and has been shown in studies involving 83 patients to constitute a most convenient and clinically effective preparation for alleviating the symptoms of this distressing chronic condition.
Publication types
-
Clinical Trial
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Aerosols
-
Antipruritics / administration & dosage*
-
Double-Blind Method
-
Drug Combinations
-
Female
-
Humans
-
Hydrocortisone / administration & dosage*
-
Hydrocortisone / therapeutic use
-
Lidocaine / administration & dosage*
-
Lidocaine / therapeutic use
-
Male
-
Middle Aged
-
Pruritus Ani / drug therapy*
Substances
-
Aerosols
-
Antipruritics
-
Drug Combinations
-
perinal
-
Lidocaine
-
Hydrocortisone